Anne Marie Nelson

Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial

Gregory L. Beatty, Mark H. O’Hara, Simon F. Lacey et al. · Gastroenterology · 2018 · 487 citations · Full text

Cancer Immunosurveillance, Pancreatic Cancer, Immunology +5

Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers

Andrew R. Haas, János L. Tanyi, Mark H. O’Hara et al. · Molecular Therapy · 2019 · 357 citations · Full text

Peptides Identified through Phage Display Direct Immunogenic Antigen to Dendritic Cells

Tyler J. Curiel, Cindy Morris, Michael J. Brumlik et al. · The Journal of Immunology · 2004 · 110 citations · Full text

Treating Relapsed / Refractory (RR) AML with Biodegradable Anti-CD123 CAR Modified T Cells

Katherine D. Cummins, Noelle V. Frey, Anne Marie Nelson et al. · Blood · 2017 · 110 citations

Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy

Alfred L. Garfall, Adam D. Cohen, Sandra P. Susanibar-Adaniya et al. · Blood Cancer Discovery · 2022 · 69 citations · Full text